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Pharmacy Research at URI: Mining Red Maple
(Acer rubrum) Trees for Novei Therapeutics
to Manage Diabetes
Navindra P. Seeram, PhD, Jialin Xu, PhD, Liya Li, PhD, and Angela Slitt, PhD
TYPE 2 DIABETES MELLITUS (T2DIVI)
accounts for about 90% of all diagnosed
cases of diabetes in adults. Over 200 mil-
lion people suffer from this disease world-
wide. In the United States alone, in 2007,
10% of American adults had diabetes and
the cost of management was $174 billion
and this figure is expected to skyrocket
(Centers for Disease Control and Pre-
vention, 2010). Plants and their derived
products have been used for centuries by
various cultures as traditional medicines
for the management of diabetes. Plants
contain secondary metabolites (known
as phytochemicals; 'phyto' means plant),
which are implicated in the prevention
and treatment of several chronic human
diseases, including diabetes. Among
these natural products, polyphenols and
phenolic glycosides, have attracted sig-
nificant interests for their anti-diabetic
properties.
Plant polyphenols as a-glucosidase
inhibitors. Dietary carbohydrates are
hydrolyzed by pancreatic a-amylase
with absorption aided by a-glucosidases
and thus, inhibition of the activities of
these enzymes is a promising approach
for managing T2DM. In fact, the clini-
cal a-glucosidase inhibitor, acarbose,
has been shown to effectively reduce
glycated hemoglobin levels when given as
monotherapy or as an add-on to other an-
tidiabetic drug treatment.' Additionally,
a fixed dose combination of acarbose and
metformin was reported to be superior to
metformin alone in controlling HbAlc,
fasting blood glucose, and post prandial
blood glucose levels in T2DM patients,^  as
well as, enhancing the blood glucose con-
trol.' Multiple plant-derived polyphenols
have been investigated as a-glucosidase
inhibitors. Extracts from grape seeds and
green tea been demonstrated to exert
inhibition on a-glucosidase activity.'* We
recently have shown a similar activity
for phenolic-enriched extracts from the
bark oí Acer rubrum, commonly known
as red maple.
Study of maple for novel therapeu-
tics. The sugar maple {Acer saccharum)
and red maple plant species are native
to eastern North America and highly
regarded for their sap which is used to pro-
duce the natural sweetener, maple syrup.
Our laboratory has recently identified a
number of phenolic compounds native
in maple plant parts that are also present
in maple syrup.^
Here we report a case study in which
the ability of red maple bark extract
(MBE) to decrease elevation of blood
glucose levels was investigated. Male
adult C57BL/6 mice were administered
MBF in combination with a bolus sucrose
challenge to evaluate the effect of MBE
or acarbose on a-glucosidase activity in
vivo according to described methods.^ ' As
expected, mice receiving a bolus sucrose
challenge increased blood glucose con-
centration 30, 60, and 90 minutes after
administration compared to initial blood
glucose concentration. (Figure 1) Both
MBE and acarbose significantly lowered
blood glucose concentrations at these time
intervals afi:er the sucrose challenge. Com-
pared to acarbose, MBE was less effective,
but did impart a significant inhibitory
effect. We now hope to further purify
and evaluate individual phytochemicals
of MBF to evaluate for activity against
sucrose-induced glucose elevation.
We have demonstrated that phenolic
glycosides are present in various maple
constituents. The isolated compounds
and extracts inhibit a-glucosidase activity
in vitroJ-* Recently, multiple gallotannins,
named maplexins A-E, were isolated
from red maple stems and bark.^ '* These
maplexin compounds were shown in vitro
to possess more activity than acarbose for
inhibition of a-glucosidase activity (IC^ ^^
= 8 vs. 160 pM; maplexin E vs. acarbose,
respectively). These interesting maplexin
compounds, that are as effective as ac-
arbose in vitro, will be further evaluated
and developed to determine whether they
impart beneficial properties in preventing
blood glucose elevations in vivo. Overall,
we determined that MBE contains bioac-
tive constituents that can potentially aid
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Figure 1. Adult male C57BL/6 mice were administered sucrose (3g/kg BW), sucrose
and acarbose (3g/kg BW + 3 mg/kg BW), or 3) sucrose and maple bark extract (3g/kg
BW+150mg/kg BW) by oral gavage. Blood glucose levels were determined by tail bleed at 0,
30, 60, 90, and 120 minutes post sucrose administration. An asterisk (*) denotes statistical
significance (p<0.05) from the sucrose treatment group.
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in the regulation of blood glucose control
after a carbohydrate challenge.
We will continue to explore how
bioactive extracts and molecules isolated
from plants can impart beneficial effects
on metabolic syndrome. As metabolic
syndrome encompasses T2DM, dyslipi-
demia, systemic inflammation, and non-
alcoholic fatty liver disease, the potential
therapeutics isolated will be tested in
various cell-based and in vivo models. We
are currently exploring anti-inflammatory
effects of maple-derived extracts and
compounds, as well as, the potential for
plant-derived extracts to augment weight
loss andT2DM therapies. Ultimately, we
hope that identification of beneficial com-
ponents in foods commonly consumed
can arm the consumer with information
to make better food choices that can be
synergistic with drug therapies used to
treat T2DM. We also will continue to
mine botanicals for potential therapies
to treat T2DM or enhance activity of
commonly prescribed anti-diabetes
therapies.
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